A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements than the ...

In previous articles, I introduced retinal reserve as a framework for understanding the retina’s ability to maintain function ...

A national NHANES analysis of 9,405 U.S. adults aged 50 and older found that any yogurt, prebiotic, or probiotic consumption ...

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced it ...

Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes (T2D), announced that the ReCET Clinical Study has reached full enrollment. A ...

Eli Lilly shares hit a record high Tuesday after IPO stock Kailera Therapeutics posted lackluster test results for its weight-loss pill.

A landmark Swedish study published Tuesday found that the composition of bacteria in your gut can reliably flag your risk of developing type 2 diabetes years before blood sugar levels reach any ...

Endogenex announced today that it completed enrollment in the ReCET clinical study of its endoscopic diabetes treatment.

July 7 (Reuters) - Kailera Therapeutics said on Tuesday its oral obesity and diabetes drug met the main goal of two ...

A 2026 State-of-the-Art review updates the ABCs of cardiovascular disease prevention to help clinicians apply contemporary risk assessment, lifestyle, pharmacologic, and cardiometabolic strategies in ...